Navigation Links
Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free,Response Across Multiple Attacks

Nearly Twice as Many Patients Taking Trexima were Migraine Free Compared to Placebo

CHICAGO, June 08, 2007 /PRNewswire/ -- New data from two large trials show that Trexima, when taken early, was nearly twice as effective as placebo in eliminating all traditional migraine symptoms at two and four hours across multiple attacks with just one tablet. The findings will be presented tomorrow at the 49th Annual Scientific Meeting of the American Headache Society.

In addition to head pain, migraine attacks often include nausea, vomiting and sensitivity to light or sound, making it difficult for sufferers to participate in daily activities. Most migraine studies focus on pain relief or pain-freedom, which only assesses head pain. This is one of the few studies to measure migraine-free response across multiple attacks, which is significant because it means that the associated symptoms of migraine, as well as the head pain, are gone.

"I believe this key endpoint will have more meaning to patients, as it measures when the whole migraine is gone rather than just the head pain," said Dr. Paul Winner, lead author and director of the Palm Beach Headache Center. "In these studies we found Trexima consistently eliminated migraine symptoms in more patients without the need for rescue medication."

Trexima, the proposed brand name for a single tablet containing sumatriptan 85 mg formulated with RT Technology(TM) and naproxen sodium 500 mg, is currently under review by the FDA for the acute treatment of migraines in adults.

About the Studies

The data are from two identical multi-center, double-blind, placebo- controlled cross-over studies of adult migraine sufferers. Migraine-free response is defined as freedom from migraine pain, nausea, vomiting, sensitivity to light and sound, and without the use of rescue medication at or before the time points specified. Subjects were randomized to one of five
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Trexima (Sumatriptan/Naproxen Sodium) Provided Relief of Both Traditional and Non-traditional Migraine Symptoms
2. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Efficacy Across Multiple Migraine Attacks
3. Trexima (Sumatriptan/Naproxen Sodium) Superior Efficacy Data Published in JAMA
4. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
5. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
6. Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic Control in Subjects with Type 2 Diabetes Compared to Metformin Alone
7. Investigational Study Demonstrated a Re-Establishment of Clinical Improvement with Orencia (Abatacept) in Children with Juvenile Idiopathic Arthritis upon Re-Introduction of Therapy
8. Study Demonstrated Rozerem (ramelteon) Does Not Affect Middle-of-the-Night Balance in Older Adults with Insomnia
9. Repros Reports That Proellex Has Demonstrated Superior Efficacy and Safety in Endometriosis When Compared to Standard of Drug Care
10. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial as Compared to Neostigmine
11. Organons Sugammadex Demonstrated a 9-12 Times Faster Recovery in Phase III Pivotal Trial Compared to Neostigmine

Post Your Comments:
(Date:11/19/2009)...19 In response to an ever-increasi...gal medicines, Operation Pangea II, involving 24 c...d Health Organization,s International Medical Prod...hlight the dangers of buying medicines online. ,...eries of arrests and the seizure of thousands of p...
(Date:11/19/2009)...f., Nov. 19 Alexza Pharm...that its corporate presentation will be webcast li...e Conference on Wednesday, December 2, 2009 at 9:0...cast from The New York Palace Hotel in New York an...ident and CEO. ,, To access the live presenta...
(Date:11/19/2009)... Nov. 19 Ligon Discovery, Inc., wh...hnology to find drugs against high-value targets, ...ancing led by incTANK Ventures. The company will u...ampaign that will screen over 100 high-value disea...Ventures General Partner Christian Bailey joins th...
Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3Stryker Announces Agreements To Acquire Assets 6148 1Stryker Announces Agreements To Acquire Assets 6148 2Stryker Announces Agreements To Acquire Assets 6148 3Transcept Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference on November 17 6146 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 1Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 2Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 3Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 4Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 5Sanofi aventis and Regeneron Expand Strategic Antibody Collaboration 6144 6
...ented at the ASCO Cancer Conference, NORTH HOLLYWO.../,-- The International Myeloma Foundation (IMF)-su...y and support for myeloma patients,families, rese...,follow-up to a Phase 3 multi- national clinical t...E(R) improves the probability of,survival by 41%. ...
...ANDS, Texas--(BUSINESS WIRE)--Jun 5, 2007 - Repros...ne results of a,six month U.S. Phase 3 study of An...e normal testicular function in men with,secondary...inferiority in all the endpoints of the study, com... treatment for low,testosterone., Study Details an...
Other Medicine Technology:Study Shows Velcade Plus Doxil Improves Survival in Previously,Treated Patients With Multiple Myeloma 2Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 2Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 3Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 4Repros' Androxal Shows Highly Statistically Significant Positive,Effects in Men with Secondary Hypogonadism 5
(Date:11/22/2009)... HealthSmart, an innovative ...ced that it has successfully completed a recapital...mpany’s other lenders. Silver Point Capital...wich, Connecticut. This recapitalization allows t...s business strategy. , , ...
(Date:11/22/2009)... Man & Machine post You ...versus the competition , ... keyboard users interested in learning what a real...o tune into “Really Cool Keyboard vs Washabl.... The film demonstrates how the premium, Really ...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswir... voted to proceed to Senator Reid,s version of the...eral objectionable items included in this bill; li...ates, is the government funding for elective abort...onable. Additionally the bill provides subsidies f...
(Date:11/21/2009)... , "This bill provides for an unpreceden...s health care about if it is not for preserving an...d, it must be defeated." Charmaine Yoest ,, ...ricans United for Life Action President and CEO Dr...he Senate by releasing the following statement: ,...
(Date:11/21/2009)... , WASHINGTON, Nov. 21 /PRNewswire-USNewswi... to eliminate onchocerciasis (river blindness) in ...nce of the disease in recent years, as evidenced b...iring mass drug administration in six endemic coun...nual meeting of the American Society of Tropical M...
Breaking Medicine News(10 mins):Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Waterproof, Cleanable Computer Keyboard Video Comparison Now Available on You Tube 2Health News:FRC: Senate Votes to Proceed with Abortion Funding Debacle 2Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4
...Crdentia Corp. (OTC Bulletin,Board: CRDT), a leadi...at,AudioStocks.com has posted an exclusive intervi...ational Director of Travel Services. In the inter...e also provides an overview of the travel nursing ...
...-Dankworth Part of a Team that Provided Critical S...days, SAN DIEGO, Oct. 1 Dr. Kim Corrigan-Dankwor...akes up La Costa Dental,Excellence, a North County.... Corrigan-Dankworth traveled to the Dominican,Rep...
...ovide the information and incentives needed to hel... CHICAGO, Oct. 1 UniCare is now offering Solaura,...e the way consumers think about,health care, help ...ne of,consumer-driven health plans (CDHP) that wou...
...Track Launches During Breast Cancer Awareness Mont..., one of,the lingering effects of chemotherapy is ...chemobrain." The lost keys, the forgotten appointm...reated by CogniFit,Ltd., helps women regain their ...
...ultz Investigates the "Social Brain" in Children w...ADELPHIA, Oct. 1 An internationally,prominent exp... with,autism, Robert T. Schultz, Ph.D., is joining...ost recently the director of the Yale Developmenta...
...h Team Director and Key Strategy Architect to Buil... Changes to Advance in Parkinso...ichael J. Fox,Foundation for Parkinson,s Research .... Ms. Hood, who joined the,Foundation in September...
Other Medicine News:Health News:Crdentia's National Director of Travel Services Provides an Exclusive Interview on the Growth of Crdentia's Travel Nurse Division 2Health News:San Diego Dentist Haunted by Smiles in Dominican Republic 2Health News:UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions 2Health News:UniCare Introduces Consumer-Driven Health Products to Give Consumers a Bigger Role in Health Care Decisions 3Health News:New Software Program Helps Breast Cancer Survivors and Patients Fight Chemofog 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 2Health News:Brain Imaging Expert Recruited to Study Autism at The Children's Hospital of Philadelphia 3Health News:Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation 2
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
...oratories is a national reference laboratory and a...h and development. ARUP offers an extensive test m...clinical and anatomic pathology. Owned by the Univ... more than half of the nation's university teachin...
Medicine Products: